Viewing nowCombinationAtorvastatin 10/20 mg (Ezetimibe, Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Trihydrate 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.

MFDS item code 202101592 · Approved 2021.02.18 · Insurance code 646005230
Reduction of cholesterol in hypercholesterolemia (primary, homozygous familial) and dyslipidemia and suppression of cardiovascular disease risk by increasing HDL.
This drug is used as an adjunct to diet to lower total cholesterol, LDL cholesterol, Apo B, triglycerides, and non-HDL cholesterol levels in patients with primary hypercholesterolemia or mixed dyslipidemia, while increasing HDL cholesterol levels. It may be administered in patients with homozygous familial hypercholesterolemia as an adjunct to other therapies or when other therapies are not effective. This medication should be used along with appropriate dietary measures to reduce the risk of atherosclerotic vascular disease through lipid control, and it is important to first identify and treat any secondary causes of dyslipidemia. Regular blood lipid tests are performed to evaluate treatment effectiveness, and the treatment plan should be adjusted as necessary. This drug helps improve healthy vascular conditions by assisting in the control of complex dyslipidemia.
This medication is administered once daily without regard to meals. The dosage range is 10/10mg to 10/80mg once a day, with an initial recommended dose of 10/10mg or 10/20mg daily. If greater reduction of LDL cholesterol is needed, a daily dose of 10/40mg is advised. After initiating treatment or adjusting the dosage, the blood lipid levels should be checked at least two weeks apart. For homozygous familial hypercholesterolemia
This drug has a rare side effect that can cause severe damage to muscles called rhabdomyolysis. Particularly, caution is needed as the risk of this side effect is higher in patients with severe infections, hypotension, major surgeries or trauma, or severe metabolic disorders. This medication should not be administered to individuals with allergies to the active ingredient or components, individuals with severe liver dysfunction or persistent unexplained elevation of liver enzymes, muscle diseases, pregnant or potentially pregnant women, breastfeeding women, patients taking certain antiviral drugs, or individuals with lactose intolerance. Patients who are alcoholics, have a history of liver disease, have impaired kidney function, have hypothyroidism, a family history of muscle disorders, or have previously experienced muscle toxicity with statin drugs, individuals over 70 years of age, those taking fibrate medications together, or patients with severe muscle weakness should use this drug cautiously. During treatment, if symptoms such as myalgia, muscle weakness, fatigue, or fever occur, inform a physician immediately, and if necessary, confirm muscle damage through blood tests. If muscle damage is confirmed, the administration of this drug should be discontinued, and the reinstitution should start at a very low dose with careful observation after symptoms have improved. Since liver function abnormalities may occur, liver function tests should be conducted before and during treatment, and if symptoms of hepatitis or jaundice appear, this drug should be discontinued immediately. This drug can raise blood glucose levels, so patients at risk for diabetes should monitor their blood sugar regularly. Women who are pregnant or breastfeeding should not take this medication, and women of childbearing age should use appropriate contraceptive measures while on treatment. The safety and efficacy of this drug have not been confirmed in children; therefore, it is not recommended. Caution should be exercised in elderly patients due to the increased risk of myopathy, but no separate dose adjustment is necessary. This medication should not be administered to patients with active liver disease or persistent unexplained elevation of liver enzymes. Caution should also be taken in patients with impaired kidney function due to the risk of muscle damage. This drug may interact with multiple medications, so patients taking other drugs should inform their physician or pharmacist, especially when combined with CYP3A4 inhibitors, antiviral drugs, fibrate drugs, colchicine, cyclosporine, etc. Caution should be exercised as dizziness may occur while driving or operating machinery. In case of overdose, as there is no specific antidote, treatment must be symptomatic and supportive, with monitoring of liver function and muscle damage. Keep out of reach of children and avoid transferring to other containers.
Urticaria, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe rash with high fever, blisters, peeling skin, mucosal pain in mouth/eyes, difficulty breathing or shortness of breath, asthma attack, respiratory abnormalities accompanied by cough + fever, jaundice (yellowing of skin or eyes), extreme lethargy, sudden and severe headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis, urination
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture, and it is safe to store it at room temperature between 1 and 30 degrees Celsius.
White to pale white, double convex, rectangular film-coated tablets
30 tablets/box [10 tablets/PTP x 3]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAtorvastatin Calcium Trihydrate 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Medica Korea Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 86.8mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationEzetimibe 10mg · Atorvastatin Calcium Trihydrate 10.9mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationAtorvastatin Calcium 10.85mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 21.7mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
CombinationAtorvastatin Calcium 43.4mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea HuTex Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.